Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Cash from Financing Activities (2019 - 2026)

ADC Therapeutics has reported Cash from Financing Activities over the past 8 years, most recently at -$583000.0 for Q1 2026.

  • Quarterly results put Cash from Financing Activities at -$583000.0 for Q1 2026, down 315.13% from a year ago — trailing twelve months through Mar 2026 was $150.1 million (up 54.78% YoY), and the annual figure for FY2025 was $150.9 million, up 55.53%.
  • Cash from Financing Activities reached -$583000.0 in Q1 2026 per ADCT's latest filing, down from $57.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $98.7 million in Q2 2024 and bottomed at -$1.1 million in Q4 2024.
  • Median Cash from Financing Activities over the past 5 years was $2365.0 (2022), compared with a mean of $18.8 million.
  • The largest annual shift saw Cash from Financing Activities soared 29008830.16% in 2023 before it crashed 111900.0% in 2024.
  • Over 5 years, Cash from Financing Activities stood at -$898855.0 in 2022, then skyrocketed by 99.89% to -$1000.0 in 2023, then plummeted by 111900.0% to -$1.1 million in 2024, then surged by 5197.23% to $57.1 million in 2025, then crashed by 101.02% to -$583000.0 in 2026.
  • Business Quant data shows Cash from Financing Activities for ADCT at -$583000.0 in Q1 2026, $57.1 million in Q4 2025, and -$198000.0 in Q3 2025.